E. Basner-Tschakarjan

发表

Induction of acute phase response genes in keratinocytes following exposure to oligodeoxynucleotides

A. Mirmohammadsadegh, U. Hengge, Annett Bär, 2002, Journal of Molecular Medicine.

Uptake and trafficking of DNA in keratinocytes: evidence for DNA-binding proteins

A. Mirmohammadsadegh, U. Hengge, E. Basner-Tschakarjan, 2004, Gene Therapy.

Topical application of plasmid DNA to mouse and human skin

A. Mirmohammadsadegh, U. Hengge, E. Basner-Tschakarjan, 2005, Journal of Molecular Medicine.

Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys

J. F. Wright, X. Anguela, K. High, 2013, Science Translational Medicine.

Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice.

D. Tormo, T. Tüting, J. Wenzel, 2006, Cancer research.

Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid.

C. Rice, Arun Srivastava, H. Ertl, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9‐dependent maturation and IFN‐α production

Meredith O'Keeffe, H. Wagner, D. Tormo, 2006, The journal of gene medicine.

Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions

F. Mingozzi, E. Basner-Tschakarjan, 2014, Front. Immunol..

Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs

V. Haurigot, H. Stedman, J. F. Wright, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Comparative evaluation of CD8+CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells.

D. Tormo, T. Tüting, A. Limmer, 2007, European journal of cell biology.

Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver.

J. F. Wright, K. High, V. Arruda, 2007, Blood.

Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells.

M. Wallet, G. Rogers, R. Herzog, 2017, Blood.

Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes

D. Scott, A. D. De Groot, V. Haurigot, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells.

H. Ertl, R. Herzog, A. Srivastava, 2013, Blood.

Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus.

T. Bieber, J. Wenzel, T. Tüting, 2005, The Journal of investigative dermatology.

Reaction of Keratinocytes to Exogenous DNA

A. Mirmohammadsadegh, U. Hengge, Annett Bär, 2002, Cells Tissues Organs.

Long-term safety and efficacy of factor IX gene therapy in hemophilia B.

Michael Recht, Pratima Chowdary, Deepak Raj, 2014, The New England journal of medicine.

Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.

Pratima Chowdary, Savita Rangarajan, Cecilia Rosales, 2011, The New England journal of medicine.

Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation.

M. Barbacid, M. Malumbres, G. Merlino, 2006, The American journal of pathology.

AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells.

Etiena Basner-Tschakarjan, M. Betts, J. Kastelein, 2009, Blood.

AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes

Etiena Basner-Tschakarjan, H. Ertl, K. High, 2015, Molecular therapy. Methods & clinical development.

Pre-Clinical Assessment of Immune Responses to Adeno-Associated Virus (AAV) Vectors

E. Basner-Tschakarjan, A. Martino, Enoch Bijjiga, 2014, Front. Immunol..

GENE THERAPY Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-speci fi c CD 8 1 T cells

H. Ertl, R. Herzog, A. Srivastava, 2013 .

Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors.

J. Orange, K. High, Shangzhen Zhou, 2009, The Journal of clinical investigation.

AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized Models

Aaron D. Black, J. Bennett, L. Sullivan, 2013, PloS one.

Long-term safety and efficacy of factor IX gene therapy in hemophilia B.

M. Kay, A. Nienhuis, J. Gray, 2014, The New England journal of medicine.

Modulation of CD8 Modulation of CD8 ++ T cell responses to AAV vectors with IgG- T cell responses to AAV vectors with IgG-derived MHC class II epitopes derived MHC class II epitopes

V. Haurigot, Shangzhen Zhou, F. Mingozzi, 2022 .

Suppression of CTL Responses against AAV-Capsid Epitopes by Peptide-Induced Regulatory T Cells.

K. High, Shangzhen Zhou, F. Mingozzi, 2009 .

Peptide-Induced Antigen-Specific CD4+CD25+FoxP3+ T Cells Suppress Cytotoxicity T Cell Responses Directed Against the AAV Capsid.

K. High, F. Mingozzi, W. Martin, 2010 .

AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells.

M. Betts, J. Kastelein, K. High, 2009, Blood.